Mikhail Blagosklonny is a well known and highly respected scientist that devotes his studies to Cancer as well as the aging process. Previously, Mikhail Blagosklonny was on staff at the Roswell Park Cancer Institute as a Professor of Oncology. The Roswell Park Cancer Institute is a well known Cancer research institute in New York.
After many years of research and intensive study, Mikhail Blagosklonny now believes that “TOR” Signaling plays a definite role in the development of Cancer. In addition, he also has formed several theories about the role that “TOR” may also play regarding the aging process in humans and learn more about Mikhail.
Blagosklonny’s main areas of interest are in the field of targeted Cancer therapies. Essentially, developing Cancer drugs that only target and destroy Cancer cells leaving healthy cells intact. Mikhail Blagosklonny believes that one day cancer drugs such as this will be readily available and will be considered a major scientific breakthrough.
Most Cancer drugs may effectively destroy Cancer cells. However, the major disadvantage with these current drugs is that they also destroy healthy, useful cells within the body. Thus causing immune and other problems for the Cancer patient and more information click here.
Mikhail Blagosklonny has researched the drug “Rapamycin”. Rapamycin is a Cancer drug that Blagosklonny believes may be useful in slowing down and possibly reversing the natural aging process. More research is needed concerning this drug. However, Mikhail Blagosklonny believes the drug has other very useful properties.
In addition to his research, Mikhail Blagosklonny is also the editor of “Cancer Biology & Therapy”. In addition, Blagosklonny also became a member of an editorial board called “Cell Death & Differentiation”.
Mikhail Blagosklonny does have his share of critics also. Jeffrey Beall does not fully agree with Blagosklonny’s theories on reversing the aging process by employing the use of the drug “Rapamycin”. Jeffrey Beall foresees other serious problems if in fact Rapamycin was used in the future for altering the natural process of aging and Makhail lacrosse camp.
Mikhail Blagosklonny does not allow other critics to interfere with is research and future goals. He is quite driven and he plans to continue to devote his time and energy researching Cancer, New treatment options as well as one day possibly altering the aging process in humans.
Mikhail Blagosklonny has some impressive education credentials. He earned both his MD in Internal Medicine as well as his PHD from First Pavlov State Medical University. Following his graduation from Pavlov State Medical University, Blagosklonny held a position for a brief period at the New York Medical College.